Japan Genetic Research Firm Licenses iPS Method To French Company
This article was originally published in PharmAsia News
Executive Summary
iPS Academia Japan and Cellectis of France have signed an agreement for the Japanese firm to license to the French company a patent for creating induced pluripotent stem cells